Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SS)
- Previous Close
264.36 - Open
265.99 - Bid 266.46 x --
- Ask 266.47 x --
- Day's Range
262.00 - 269.08 - 52 Week Range
134.55 - 299.99 - Volume
724,088 - Avg. Volume
1,269,740 - Market Cap (intraday)
106.854B - Beta (5Y Monthly) 1.27
- PE Ratio (TTM)
-- - EPS (TTM)
-4.55 - Earnings Date Apr 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. Sichuan Biokin Pharmaceutical Co.,Ltd. was founded in 2006 and is based in Chengdu, China.
www.baili-pharm.com2,521
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 688506.SS
View MorePerformance Overview: 688506.SS
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688506.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688506.SS
View MoreValuation Measures
Market Cap
106.01B
Enterprise Value
105.17B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
247.32
Price/Book (mrq)
31.44
Enterprise Value/Revenue
245.71
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
63.67%
Return on Assets (ttm)
53.82%
Return on Equity (ttm)
183.64%
Revenue (ttm)
5.82B
Net Income Avi to Common (ttm)
3.71B
Diluted EPS (ttm)
-4.55
Balance Sheet and Cash Flow
Total Cash (mrq)
5.75B
Total Debt/Equity (mrq)
53.23%
Levered Free Cash Flow (ttm)
2.69B